This inventor holds 2 USPTO granted patents. Top assignees: Cornell University, University System of Maryland. Active years: 2014-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2014-2018
Title: Leandro Carlos A Cerchietti: Innovator in Cancer Treatment
Introduction
Leandro Carlos A Cerchietti is a notable inventor based in New York, NY (US). He has made significant contributions to the field of cancer research, particularly through his innovative patents. With a total of 2 patents, Cerchietti's work focuses on developing new methods for treating cancer.
Latest Patents
Cerchietti's latest patents include groundbreaking inventions such as "BCL6 inhibitors as anticancer agents." This invention provides compositions and methods for blocking the BCL6 BTB domain with small molecule, non-peptide compounds. BCL6 is a transcriptional repressor that plays a crucial role in the normal development of germinal center B-cells and is often implicated in diffuse large B-cell lymphomas. Another significant patent is the "Method for treating cancer," which relates to a process of treating cancers that are particularly susceptible to radiation therapy by administering an amino acid alongside radiation therapy.
Career Highlights
Throughout his career, Cerchietti has worked with prestigious institutions, including Cornell University and the University System of Maryland. His research has contributed to advancements in cancer treatment methodologies, showcasing his commitment to improving patient outcomes.
Collaborations
Cerchietti has collaborated with esteemed colleagues such as Ari Matthew Melnick and Mariano G Cardenas. These partnerships have further enhanced his research and innovation in the field of oncology.
Conclusion
Leandro Carlos A Cerchietti stands out as an influential inventor in cancer research, with his innovative patents paving the way for new treatment options. His dedication to advancing medical science is evident through his work and collaborations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile